Allocetra: Off-The-Shelf, Universal, Macrophage Reprogramming Cell Therapies For Life-Threatening Diseases Including Solid Tumors

Time: 2:30 pm
day: Day 1 - Track B - Lunch


  • Introducing  Allocetra – a new modality of macrophages reprogramming into their homeostatic state for treatment of unmet medical conditions
  • Presenting significant synergistic anti-cancer combination therapy effect of Allocetra and CAR-T in human cervical cancer mice model
  • Discussing the transition into first in human clinical studies in peritoneal metastasis